• Philadelphia Pharma
  • Philadelphia Pharma Philadelphia Pharma
    • Home
    • About us
    • Therapeutic Areas
    • BLOG
    • News & Events
    • MEDIA
    • Register Now
    • Français
  • CONTACTEZ-NOUS

    Blog

    • Home
    • BLOG

ESC 2026 Hotlines: Newsletter of the College of Cardiology and Cardiovascular and Peripheral Vascular Surgery

  • October 5, 2026
  • philadelphia-pharma
  • Guidelines

This edition highlights the major studies presented at the 2026 European Society of Cardiology Congress, bringing new evidence , and stimulating the clinical thinking : providing a..

  • Lire plus

Anticoagulation for Atrial Fibrillation with intermediate stroke risk

  • September 17, 2026
  • philadelphia-pharma
  • Clinical Studies

Discover the results of the SINGLE-AF study, recently published in the New England Journal of Medicine, providing new data on the use of direct oral anticoagulants in..

  • Lire plus

2026 AHA/ACC/ADA/ASN Guidelines for the management of Cardiorenal-Metabolic Syndrome

  • June 17, 2026
  • philadelphia-pharma
  • Guidelines

2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome Télécharger l’article complet (PDF)

  • Lire plus

ACC/AHA 2026 Recommendations for the Management of Pulmonary Embolism

  • June 17, 2026
  • philadelphia-pharma
  • Guidelines

2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults Download the full article (PDF)

  • Lire plus

COMBAT-AF: Anticoagulants and Atrial Fibrillation

  • March 19, 2026
  • philadelphia-pharma
  • Clinical Studies

COMBAT-AF: Comparative Analysis of the Net Clinical Benefit of Direct Oral Anticoagulants in Atrial Fibrillation The COMBAT-AF study evaluates, through a systematic review and meta-analysis of randomized..

  • Lire plus

Clinical Studies

  • November 3, 2025
  • philadelphia-pharma
  • Clinical Studies

Clinical Studies Comparison of the Efficacy and Tolerability of Rosuvastatin Versus Atorvastatin in Patients with Ischemic Stroke Download the complete article (PDF)

  • Lire plus

AI in Pharma: A Driving Force for Innovation

  • October 27, 2025
  • philadelphia-pharma
  • Research & Development

In an industry where precision, speed, and safety are critical, artificial intelligence (AI) is reshaping traditional methods and opening new horizons in the pharmaceutical sector. From fundamental..

  • Lire plus

The 10 Greatest Medical Discoveries That Changed the World

  • October 27, 2025
  • philadelphia-pharma
  • History of Medicine Public Health

Over the centuries, certain medical discoveries have permanently transformed the way we treat, live, and approach health. The invention of the vaccine by Edward Jenner at the..

  • Lire plus

Nanomedicine: Revolutionizing Targeted Treatment

  • October 27, 2025
  • philadelphia-pharma
  • History of Medicine

Nanomedicine, an innovative branch of medical science, is quietly emerging as a major revolution in the fight against complex diseases such as cancer, neurological disorders, and chronic..

  • Lire plus

Recent Posts

  • ESC 2026 Hotlines: Newsletter of the College of Cardiology and Cardiovascular and Peripheral Vascular Surgery
  • Anticoagulation for Atrial Fibrillation with intermediate stroke risk
  • 2026 AHA/ACC/ADA/ASN Guidelines for the management of Cardiorenal-Metabolic Syndrome
  • ACC/AHA 2026 Recommendations for the Management of Pulmonary Embolism
  • COMBAT-AF: Anticoagulants and Atrial Fibrillation

Categories

  • Clinical Studies
  • Guidelines
  • History of Medicine
  • Public Health
  • Research & Development
Direction médicale :

Philadelphia Promotion | Centre Urbain Nord - Immeuble Coral,
Avenue Zohra Faiza BLOC B - 10 EME ETAGE Tunis, 1082

Site industriel :

Philadelphia Pharma | Zone Industrielle – Km 4 Route de Sfax – 3000 Sfax, Tunisie

Contactez-nous

[email protected]
  • © Copyright 2025. All rights reserved. Philadelphia-Pharma

Philadelphia Pharma
  • Home
  • About us
  • Therapeutic Areas
  • BLOG
  • News & Events
  • MEDIA
  • Register Now
  • Français